文献速递关节外科

围手术期使用选择性5-羟色胺再摄取抑制剂与全髋和全膝关节置换术输血风险增加相关

Perioperative Selective Serotonin Reuptake Inhibitor Use Is Associated With an Increased Risk of Transfusion in Total Hip and Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2019-06-22

该研究基于机构数据库分析2013年1月至2017年12月全髋关节置换术4485例和全膝关节置换术5584例,按是否使用选择性5-羟色胺再摄取抑制剂(SSRI)分层。结果显示SSRI使用与失血量增加显著相关(P < .004),并预测输血风险(比值比1.476;P < .001),尤其在全髋关节置换术中。作者认为SSRI使用是全关节置换术围手术期可改变的重要因素,但需进一步研究替代抗抑郁药物。

要点

  • SSRI使用者输血率:全膝关节置换术组3.9%,全髋关节置换术组8.5%。
  • 控制年龄、性别、体质指数、凝血病、手术类型和SSRI状态后,SSRI使用与失血量增加显著相关(P < .004)。
  • SSRI使用预测输血风险(比值比1.476;P < .001),尤其在全髋关节置换术中。

核心结论

  • SSRI使用与全关节置换术围手术期失血量增加相关,并预测输血风险,尤其在全髋关节置换术中。
  • 作者认为SSRI使用是全关节置换术围手术期可改变的重要因素,但需进一步研究围手术期抑郁症的潜在替代药物。

研究设计与样本

  • 回顾性分析机构数据库2013年1月至2017年12月全髋关节置换术4485例和全膝关节置换术5584例,按手术时是否使用SSRI分层比较两组。

主要发现

  • SSRI使用者输血率在全膝关节置换术组为3.9%,在全髋关节置换术组为8.5%。
  • 控制年龄、性别、体质指数、凝血病、手术类型(全髋 vs 全膝)和SSRI状态后,SSRI使用与失血量增加显著相关(P < .004)。
  • 控制相同变量的逻辑回归显示SSRI使用预测输血风险(比值比1.476;P < .001)。

关键数值与推荐

  • SSRI使用者输血率:全膝关节置换术组3.9%,全髋关节置换术组8.5%。
  • SSRI使用与失血量增加相关(P < .004),预测输血风险(比值比1.476;P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) have been shown in both orthopedic and general surgery literature to be associated with an increased risk of blood loss, and this is thought to occur via diminished platelet serotonin reuptake and subsequent decline in platelet aggregation potential. In this study, we aim at quantifying the effect of treatment with SSRIs on blood loss and transfusion rates following total hip (THA) or total knee arthroplasty (TKA). METHODS: THA (4485) and TKA (5584) cases from January 2013 to December 2017 at the investigating institution were queried and analyzed separately from an institutional database. Patients were stratified by utilization of an SSRI at the time of surgery. Patient demographics, baseline coagulopathy, preoperative and postoperative hemoglobin, transfusion, and length of stay were obtained to compare the 2 cohorts. RESULTS: The transfusion rate for SSRI users was 3.9% in the TKA group and 8.5% in the THA group. After controlling for age, gender, body mass index, presence of coagulopathy, procedure (THA vs TKA), and SSRI status, SSRI utilization was significantly associated with increased blood loss (P < .004), and logistic regression controlling for the same variables showed SSRI utilization to be predictive of transfusion (odds ratio, 1.476; P < .001). CONCLUSION: SSRI utilization was associated with increased perioperative blood loss and predictive of transfusion risk, particularly with THA. This represents an important factor that may be modified in the setting of total joint arthroplasty but further work will be necessary to study potential alternative medications for depression in the perioperative phase.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Belay ES, Penrose CT, Ryan SP, et al. Perioperative Selective Serotonin Reuptake Inhibitor Use Is Associated With an Increased Risk of Transfusion in Total Hip and Knee Arthroplasty. J Arthroplasty. 2019. PMID: 31477539. doi:10.1016/j.arth.2019.04.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。